Format

Send to

Choose Destination
J Matern Fetal Neonatal Med. 2018 Jul;31(13):1792-1797. doi: 10.1080/14767058.2017.1326895. Epub 2017 May 19.

The role of predictive vaginal biomarkers in women with cervical cerclage.

Author information

1
a Department of Obstetrics and Gynecology , Jamaica Hospital Medical Center , New York , NY , USA.
2
b Department of Health Science , University of Florence , Florence , Italy.
3
c Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology , Thomas Jefferson University , Philadelphia , PA , USA.

Abstract

Cervical cerclage is currently one of the primary methods of treatment for cervical insufficiency (CI). Identifying methods in order to selectively apply cerclage may allow us to further limit unnecessary procedures. In this regard, a limited number of inflammatory and extracellular matrix biomarkers measurable non-invasively at the level of the cervix have been examined. In this review we summarize the current research on the use of cervical biomarkers in predicting cerclage failure and propose potential objectives for future research.

KEYWORDS:

Cerclage; biomarkers; cervical insufficiency; preterm delivery

PMID:
28475391
DOI:
10.1080/14767058.2017.1326895
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center